This inventor holds 5 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2008-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2023
Title: Innovations by Kenneth James Henry, Jr.
Introduction
Kenneth James Henry, Jr. is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of five patents to his name, his work has the potential to impact various therapeutic areas.
Latest Patents
Among his latest patents are BTK inhibitor compounds, which provide new avenues for treatment. The invention details BTK inhibitor compounds of a specific formula, showcasing their potential in medical applications. Additionally, he has developed AKT inhibitors, which are also described in a patent. This invention includes pharmaceutical compositions comprising these compounds, their uses, and methods of application.
Career Highlights
Kenneth is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His work at Eli Lilly has allowed him to focus on developing groundbreaking therapies that address critical health issues.
Collaborations
Some of his notable coworkers include David Anthony Barda and Sajan Joseph. Their collaboration has likely contributed to the advancement of Kenneth's research and the successful development of his patented inventions.
Conclusion
Kenneth James Henry, Jr. is a distinguished inventor whose work in pharmaceuticals has led to the development of important compounds. His contributions continue to shape the landscape of medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile